•  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Applications are invited for a highly motivated and enthusiastic Postdoctoral Researcher to contribute to the research of the Radiopharmacy and Molecular Imaging Group, led by Professor Bart Cornelissen. The aim of the Group is the development of novel preclinical imaging agents for oncology. The project will be performed in collaboration with Professor Veronique Gouverneur in the Department of Chemistry. The research will be based at the Radiobiology Research Institute and the Chemistry Research Laboratories in Oxford.

You will undertake research into the development of radiolabelled agents for imaging of DNA damage in vitro and in vivo using PET imaging. The project involves the synthesis and evaluation of radiolabelled small molecules. You will be part of a team of synthetic chemists, radiochemists and biologists working towards PET imaging of DNA damage-related targets. Some degree of cross-training will be expected.

You will have (or be working towards) a PhD in organic chemistry, radiochemistry, radiopharmacy, or equivalent science, with a strong background in organic synthesis. Expertise in organic synthesis, NMR and MS techniques is also essential, together with demonstrable skill to organise, design and implement organic synthesis and radiolabelling strategies for novel small-molecule 18F-radiotracers. Evidence will be sought of a deep understanding of previous fields of research and evidence of independent intellectual and practical contributions to previous research projects, as indicators that such attributes can be brought to bear on the present project.

This is a full-time post, offered for 3 years in the first instance.

All applicants must complete a short online application form and upload a CV and supporting statement.

The closing date for applications is 12.00 noon on 7 May 2018. Interviews are scheduled for 17 May 2018.

Apply

 

.

Leave a Reply